Compare Megalestari Epack Sentosaraya Tbk. (EPAC) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Megalestari Epack Sentosaraya Tbk.Trade

UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Megalestari Epack Sentosaraya Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Megalestari Epack Sentosaraya Tbk. trades at Rp69 (market cap 234.54B, 69.7M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 584.6B, 817.3K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 2.5× Megalestari Epack Sentosaraya Tbk.'s market cap, and Megalestari Epack Sentosaraya Tbk. is more actively traded (69.7M versus 817.3K). Which is the better fit depends on your goals.

	EPAC	LABS
Market Cap	234.54B	584.6B
Volume	69.7M	817.3K
Lot	696.96K	8.17K
Turnover	4.83B	120.01M
Average Price	69.23	146.84
Value	4.83B	120.01M
Indicative Equilibrium Price	69	146
Indicative Equilibrium Volume	19.54K	59

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

EPAC

View details →

LABS

View details →

About Megalestari Epack Sentosaraya Tbk.

PT Megalestari Epack Sentosaraya Tbk ("Company") formerly PT Era Prima Adi Cipta Kreasindo and its subsidiaries (together the "Group") was established based on the Deed No.55, dated June 18, 2013 of Poppie Savitri Martosuhardjo Pharmanto, S.H., notary in Jakarta.

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.